The Norma Coles Story

Featured News

March 11, 2026Quoin Pharmaceuticals Announces FDA Grants Fast Track Designation for QRX003 for the Treatment of Netherton Syndrome

February 26, 2026NETHERTON NOW Recognizes Rare Disease Day and Highlights Growing Global Awareness of Netherton Syndrome

All News

Subscribe

Get Netherton Syndrome Updates from Quoin

This website does not provide medical advice and is for educational purposes only. Quoin Pharmaceuticals a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases NethertonNow and associated logo are trademarks of Quoin Pharmaceuticals.

All information, documentation, data, photographs, and other content herein is the property of Quoin Pharmaceuticals, Inc. and its affiliates, and is protected by worldwide copyright laws. You may use this content only for your personal use for non- commercial purposes, and no modification or further reproduction of the content is permitted. The content may otherwise not be copied or used in any way without the express written permission of Quoin Pharmaceuticals, Inc.

Privacy Policy Sitemap